This document stipulates the basic requirements for the modern pharmaceutical industry to participate in market competition in accordance with antitrust regulations, and involves guidance on organization and personnel, risk identification, risk prevention, risk assessment and disposal, establishment of a competition compliance management system, and the responsibilities of industry associations. This document is applicable to the anti-monopoly competition compliance management of the modern pharmaceutical industry in Linhai City to prevent and reduce the risk of anti-monopoly violations. Upstream chemical raw materials, pharmaceutical intermediates and other enterprises required for the production of raw materials and pharmaceutical excipients can be used as a reference.
T/LHYH 0001-2022 history
2022T/LHYH 0001-2022 Competitive Compliance Guidelines for the Modern Pharmaceutical Industry